Technology
Unique technology for antibody sequencing and discovery
Alicanto®
A better way to discover antibodies.
Alicanto® is Abterra Biosciences’ novel antibody discovery platform that identifies target-specific antibodies from serum. Our unique technology selects high-affinity antibodies without requiring time-consuming and inefficient cell selection, fusions, or cloning. Alicanto® can be applied to discover monoclonal antibodies from rabbits, llamas, goats, and humans.
Rabbit Monoclonal Antibody Discovery
Single Domain Antibody Discovery
Human Antibody Discovery
Valens™
Resurrect your monoclonal antibody using proteomic de novo sequencing.
Valens™ uses proprietary technology to sequence monoclonal antibodies when the source cell has been lost. When no source DNA/RNA is available, Valens™ uses proteomics technologies to determine the full-length amino acid sequence of a monoclonal antibody. We’ve successfully applied our approach to antibodies from multiple species, including mouse, rat, human, and hamster, and multiple isotypes, including IgG’s and IgM’s. Valens™ can also be used to sequence antibody fragments.
Protein Sequence Confirmation
Antibody Protein Sequencing
Reptor™
Antibody repertoire sequencing and analysis.
The adaptive immune response to challenge consists of a dynamic and diverse population of B- and T-lymphocytes. Reptor™ simplifies the interrogation of these populations by combining next-generation sequencing with repertoire analysis, all accessible on the cloud. From tracking individual clones across time to repertoire-wide comparisons across individuals, our Reptor™ technology provides an intuitive window into the immune repertoires of humans, llamas, alpacas, rabbits, and goats.
Next-Generation Sequencing HT Hybridoma
Next-Generation Sequencing Bulk B Cells
Next-Generation Sequencing Hit Expansion
Next-Generation Sequencing Display Library
Quorum Cloud®
Visualize and analyze structurally similar compounds.
98% of spectra in untargeted metabolomics experiments remain unidentified. This translates to missed insights in your research. Quorum Cloud® organizes unidentified spectra into families of structurally-related compounds using molecular networking, enabling the expansion of identifications to family members. Our Quorum Cloud® technology highlights differentially expressed compounds, so you can quickly focus on the compounds that matter.
Get In Touch